Nektar Therapeutics
NKTR
#6488
Rank
โ‚น69.68 B
Marketcap
โ‚น3,426
Share price
5.96%
Change (1 day)
225.77%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น688.07

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น731.43. In 2024 the company made an earnings per share (EPS) of -โ‚น813.11 an increase over its 2023 EPS that were of -โ‚น2,010.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น688.07-15.38%
2024-โ‚น813.11-59.54%
2023-โ‚น2,010-25.89%
2022-โ‚น2,712-31.12%
2021-โ‚น3,93714.86%
2020-โ‚น3,428-1.19%
2019-โ‚น3,469-163.96%
2018โ‚น5,424-725.4%
2017-โ‚น867.25-42.73%
2016-โ‚น1,51483.33%
2015-โ‚น825.9639.53%
2014-โ‚น591.94-69.29%
2013-โ‚น1,927-6.67%
2012-โ‚น2,065

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น958.06-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น157.85-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,196-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น60.57-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น696.90-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น278.53-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น6.42-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น189.97-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland